Preliminary Schedule

Download the preliminary schedule. Check back frequently for updates!

Wednesday, June 13 Thursday, June 14 Friday, June 15 Saturday, June 16

 

Wednesday, June 13

3:30 - 4:30 p.m.

Committee Meetings - Session 1
Membership, Next Generation, Clinical Practice

4:30 - 5:30 p.m.

Committee Meetings - Session 2
Website & Social Media, Publications and Communications, Education

4:00 - 6:00 p.m.

Speaker Ready Room

4:00 - 7:00 p.m.

Registration

4:00 - 7:00 p.m.

Poster Set up

5:30 - 7:00 p.m.

Early Career Program and Reception

   

Thursday, June 14

6:00 a.m. - 5:00 p.m.

Registration

6:30 - 7:45 a.m.

Breakfast, Visit Exhibits and Posters

6:30 - 7:45 a.m.

Vascular Medicine Editorial Board Meeting

6:45 - 11:30 a.m.

Speaker Ready Room

6:45 - 7:45 a.m.

Non-CME Breakfast Symposium # 1

7:55 a.m.

SVM 29th Annual Scientific Sessions - Welcome

8:00 - 9:13 a.m.    

Session 1 -  The Year in Vascular Medicine

8:05 - 8:13 a.m.

Basic Science

8:13 - 8:21 a.m.

Anticoagulants & Antiplatelets

8:21 - 8:29 a.m.

Arterial Interventions

8:29 - 8:37 a.m.

Lymphatic disease

8:37 - 8:45 a.m.

Venous Disease

8:45 - 8:53 a.m.

Editor's Choice: Best of Vascular Medicine

8:53 - 9:00 a.m.

Panel Discussion

9:00 - 10:00 a.m.

Session 2 -  Future of Vascular Imaging

10:00 - 10:20 a.m.

Break, Visit Exhibits and Posters

10:20 - 11:15 a.m.

Session 3 - Arteriopathies

10:20 - 10:29 a.m. 

Aortopathies: What, When, and How

10:29 - 10:38 a.m. 

Mesenteric Arteriopathies: Pathologies and Mimickers

10:38 - 10:47 a.m. 

FMD: Beyond the “String-of-Beads”

10:47 - 10:56 a.m. 

Cervical Artery Dissection: Syndrome or Spectrum?

10:56 - 11:05 a.m. 

Genetic Testing of Arteriopathies: A Rational Approach

11:05 - 11:15 a.m. 

Panel Discussion

11:15 - 12:15 p.m.

Session 4 - Medical Management of PAD

11:15 - 11:25 a.m.

The 2017 ESC and 2016 AHA/ACC Guidelines on Peripheral Artery Disease: Moving the Needle

11:25 - 11:35 a.m.

Managing LDL in the PAD Patient: Beyond Statin Therapy

11:35 - 11:45 a.m.

Managing Blood Pressure in the PAD Patient: Selecting Drug and Target

11:45 - 11:55 a.m.

Antiplatelet Therapy for PAD: Matching Antiplatelet Regimens and Risk Profiles

11:55 - 12:05 p.m.

Anticoagulants for PAD: Is There a Role for Novel Oral Anticoagulants?

12:05 - 12:15 p.m.

Panel Discussion

12:30 - 1:30 p.m.

Non-CME Lunch Symposium  # 2

12:30 - 1:30 p.m.

Non-CME Lunch Symposium  # 3

12:30 - 5:00 p.m.

Speaker Ready Room

1:30 - 2:00 p.m.

Visit Exhibits and Posters

2:00 - 3:00 p.m.    

Session 5 - Rapid Fire Session: Anticoagulation

2:05 p.m.

Provoked VTE – Short courses or Indefinite Anticoagulation?

2:10 p.m.

VTE Secondary Prophylaxis – When to choose DOAC vs. ASA?

2:15 p.m.

AF and ACS – How many antithrombotics and for how long?

2:20 p.m.

Rivaroxaban for CAD – what patient might be eligible? (aka Adding DOACs to DAPT)

2:25 p.m.

VTE prevention in the medically ill – is there a role for DOACs?

2:30 p.m.

DOACs for VTE – how to keep patients out of the hospital (aka outpatient treatment of DVT and PE)

2:35 p.m.

Genotype-guided dosing of Warfarin – Is there a Role?

2:40 p.m.

Strategies to improve Periprocedural Anticoagulation Management

2:45 - 3:00 p.m.

Panel Discussion

3:00 - 4:10 p.m.         

Session 6 - Jay D. Coffman Young Investigator Presentations

4:10 - 4:40 p.m.

Break, Visit Exhibits and Posters

4:40 - 5:40 p.m.

Moderated Poster Session

5:45 - 7:15 p.m.         

Celebrating Vascular Medicine Reception

   

Friday, June 15

6:00 a.m. - 5:00 p.m.

Registration

6:30 - 7:45 a.m.

SVM Member Business Meeting

6:30 - 7:45 a.m.

Breakfast, Visit Exhibits and Posters

6:45 - 11:30 a.m.

Speaker Ready Room

7:55 a.m.

Announcements

8:00 - 9:00 a.m. 

Session 7 - Chronic Venous Disease Novel Insights: AVF & SVM Joint Session

8:00 - 8:08 a.m.

Emerging treatments of superficial venous reflux: Beyond laser or radiofrequency ablation

8:08 - 8:16 a.m.

Mechanisms of valve function/dysfunction and deep venous valve interventions (reconstruction and neovalves)

8:16 - 8:24 a.m.

The role of iliac veins obstruction and pelvic vein dysfunction in chronic venous insufficiency

8:24 - 8:32 a.m.

Contribution of lymphatic dysfunction to chronic venous disease?

8:32 - 8:40 a.m.

Evolving understanding and implications of the molecular mechanisms in venous ulcers

8:40 - 8:48 a.m.

Importance of eliminating reflux below the knee for treatment of venous ulcers

8:48 - 9:00 a.m.

Panel Discussion

9:00 - 9:10 a.m.

Awards

9:10 - 9:30 a.m.

Presidential Address

9:30 -10:00 a.m.

Break, Visit Exhibits and Posters

10:00 - 11:00 a.m.

Session 8 -  Best of SVM Science Rapid Fire Oral Abstracts Session

11:00 a.m. - Noon   

Session 9 - Vascular Medicine in Value Based Medicine and Systemness - Roundtable Discussion

12:15 - 1:15 p.m.   

Vascular Jeopardy

12:30 - 5:00 p.m.

Speaker Ready Room

1:15 - 1:30 p.m.

Visit Exhibits & Posters

1:30 p.m.

Poster & Exhibit Dismantle

1:30 p.m.

Welcome to Vascular Lab

1:35 - 2:35 p.m.

Vascular Lab I: Follow-up After Interventions Arterial and Venous

1:35 - 1:45 p.m.

Advanced non-invasive vascular imaging modalities in patients undergoing carotid artery stenting

1:45 - 1:55 p.m.

Use of duplex ultrasound following renal artery interventions

1:55 - 2:05 p.m.

Vascular access complications

2:05 - 2:15 p.m.

EHIT: use of vascular lab for diagnosis and follow up

2:15 - 2:25 p.m.

Venous compression syndromes: is there a role of vascular lab for intervention planning and postoperative follow up?

2:25 - 2:35 p.m.

Panel Discussion

1:35 - 2:35 p.m.

Session 10: Endovascular Therapy for Venous Thromboembolism: Catheters, Stents, Filters, Oh My!

1:35 - 1:50 p.m.

The Known Unknowns in Management of Submassive Pulmonary Embolism

1:35 - 1:40 p.m.

Debate - Catheter-directed thrombolysis should be first line for sub-massive pulmonary embolism (Pro)

1:40 - 1:45 p.m.

Debate – Anticoagulation not catheter-directed thrombolysis should be first line for subassive pulmonary embolism (Con)

1:45 - 1:50 p.m.

Rebuttals

1:50 - 1:59 p.m.

What is the role of thrombus removal in acute proximal DVT after ATTRACT

1:59 - 2:08 p.m.

Advances in IVC Filter Removal: How Late is Too Late to Retrieve?

2:08 - 2:16 p.m.

Endovascular Therapy for Chronic Venous Obstruction

2:16 - 2:25 p.m.

Balloon pulmonary artery angioplasty for CTEPH

2:25 - 2:35 p.m.

Panel Discussion

2:35 - 3:35 p.m.

Vascular Lab II: New in Vascular Lab

2:35 - 2:45 p.m.

Temporal Artery Ultrasound and Diagnostic Role in Giant Cell Arteritis

2:45 - 2:55 p.m.

Transcranial Doppler

2:55 - 3:05 p.m.

Aortic Evaluation with Contrast ultrasound

3:05 - 3:15 p.m.

New Techniques in Radial Artery Flow Mediated Dilatation

3:15 - 3:25 p.m.

Exercise Gluteal TcPO2 for Diagnosis of Iliac Disease

3:25 - 3:35 p.m.

Panel Discussion

3:35 - 3:45 p.m.

Break - Transition to Workshops

3:45 - 4:45 p.m.  

How-To Workshops: Social Media
Workshop 1 - Option 1

3:45 - 4:45 p.m.

How-To Workshops: Venous Intervention
Workshop 1 - Option 2

4:45 - 5:45 p.m..

How-To Workshops: Social Media
Workshop 2 - Option 1

4:45 - 5:45 p.m..

How-To Workshops: Venous Intervention
Workshop 2 - Option 2

6:00 - 7:30 p.m.

Cases Over Cocktails

7:30 p.m.

Dinner on your own

   

Saturday, June 16

6:00 a.m. - 2:00 p.m.

Registration

6:45 - 5:00 p.m.

Speaker Ready Room

6:45 - 7:45 a.m.

Non-CME Breakfast Symposium #4

8:00 - 9:00 a.m.    

Session 11 - Great Debates in Vascular Medicine

8:00 - 8:05 a.m.

Superficial femoral artery disease should be treated initially with drug coated balloons, reserving stents for only secondary intervention (Pro)

8:05 - 8:10 a.m.

Superficial femoral artery disease should be treated initially with drug coated balloons, reserving stents for only secondary intervention (Con)

8:15 - 8:20 a.m.

Any patient with an abnormal ABI should have a screening carotid duplex ultrasound (Pro)

8:20 - 8:25 a.m.

Any patient with an abnormal ABI should have a screening carotid duplex ultrasound (Con)

8:30 - 8:35 a.m.

PCSK 9 drugs are underutilized for our high risk PAD patients (Pro)

8:35 - 8:40 a.m.

PCSK 9 drugs are underutilized for our high risk PAD patients (Con)

8:45 - 8:50 a.m.

Systemic thrombolysis is as effective for PE treatment as ultrasound-accelerated drug delivery

8:50 - 8:55 a.m.

Systemic thrombolysis is as effective for PE treatment as ultrasound-accelerated drug delivery

9:00 - 10:00 a.m.

Session 12 - Critical Limb Ischemia

9:00 - 9:08 a.m.

Time to Redefine Critical Limb Ischemia

9:08 - 9:16 a.m.

Limb Salvage, It Takes a Village

9:16 - 9:24 a.m.

ABCs of Wound Care

9:24 - 9:32 a.m.

Beyond Revascularization: Arterial flow pump, Sympathetic Nerve Block, and Biologic Therapy

9:32 - 9:40 a.m.

How to Address Disparities in CLI Revascularization and Lower Extremity Amputation

9:40 - 9:48 a.m.

Role of Vascular Medicine Specialist in CLI Care, Expert Opinion

9:48 - 10:00 a.m.

Panel Discussion - 3 Cased Based Multidisciplinary Discussions

10:00 - 10:30 a.m.

Break

10:30 - 11:30 a.m.

Vascular Lab III: Fundamentals

10:30 - 10:40 a.m.

Accreditation Update

10:40 - 10:50 a.m.

Image Optimization

10:50 - 11:00 a.m.

Ultrasound Artifact                     

11:00 - 11:10 a.m.

Ergonomics in the Vascular Lab

11:10 - 11:20 a.m.

Common Interpretation Errors in the Vasc Lab     

11:20 - 11:30 a.m.

Panel Discussion

11:30 - 11:45 a.m.

Pick Up Lunch for Vascular Lab IV

11:45 a.m. - 12:45 p.m.   

Vascular Lab IV: Mock RPVI Exam

12:45 - 1:45 p.m.

Vascular Lab V: Venous Disease

12:45 - 12:55 p.m.

Role of the vascular lab in the management of upper extremity venous thrombosis

12:55 - 1:05 p.m.

Protocols for the evaluation of lower extremity venous reflux: supine, sitting, or standing?

1:05 - 1:15 p.m.

Diagnosis of abdomino-pelvic venous compression syndromes

1:15 - 1:25 p.m.

The role of ultrasound in superficial venous interventions

1:25 - 1:35 p.m.

New developments in physiologic testing for venous disease

1:35 - 1:45 p.m.

Panel Discussion

1:45 - 2:00 p.m.

Break

2:00 - 3:00 p.m.    

Vascular Lab VI: Risk Assessment

2:00 - 2:10 p.m.

Carotid plaque echogenicity in risk assessment

2:10 - 2:20 p.m.

PAD vein graft imaging and risk assessment

2:20 - 2:30 p.m.

Residual venous thrombosis and risk of DVT recurrence

2:30 - 2:40 p.m.

Exercise TcPO2 in claudication assessment

2:40 - 3:00 p.m.

Panel Discussion/Conclusion

3:00 p.m.

SVM 29th Annual Meeting Concludes

Tweets by SVM_tweets
Contact